For most people, depression treatment works. About half respond to the first antidepressant they try, and many of the rest respond to a second. But a meaningful minority — by some estimates around a third of people with major depression — don't get adequate relief from the first couple of standard treatments. When that happens, the depression is sometimes labeled treatment-resistant.
It's a discouraging term to hear. But it's worth understanding precisely, because the label is often less final than it sounds — and because it opens the door to a set of options that work for many people who didn't respond to first-line treatment.
What "treatment-resistant" actually means
The most common definition is depression that hasn't responded adequately to two or more antidepressant trials of adequate dose and duration. Each part of that definition matters:
- Adequate dose. A medication tried at too low a dose isn't a fair trial. Many "failed" medications were simply never titrated to a therapeutic level.
- Adequate duration. Antidepressants take 4–6 weeks (sometimes 8) to show full effect. Stopping at two weeks because "it isn't working" doesn't count as a completed trial.
- Adherence. A medication taken irregularly hasn't really been tried.
This is why the first step when depression seems resistant is often not a new treatment but a careful review of the old ones. A surprising number of cases labeled treatment-resistant turn out to involve under-dosing, too-short trials, or missed doses — all of which are fixable.
What else gets reassessed
Before escalating, a thorough clinician will also check for things that can make depression look resistant when something else is going on:
The diagnosis itself. Bipolar depression, for instance, often doesn't respond to standard antidepressants — and can be worsened by them. If there's any history of elevated mood, high energy, or impulsivity, that changes the treatment entirely. Conditions like thyroid dysfunction, anemia, sleep apnea, and chronic pain can also produce or mimic depression.
Co-occurring conditions. Untreated anxiety, PTSD, ADHD, or substance use can all keep depression locked in place. Treating depression alone while one of these runs unaddressed often fails.
Ongoing stressors. Sometimes the issue isn't the brain but the situation. An abusive relationship, financial crisis, or chronic overwork can sustain depression no matter what medication is added. This doesn't mean the depression "isn't real" — it means treatment has to include the context.
The escalation options
When the basics have been checked and depression remains resistant, several evidence-based strategies exist. These are specialty-level decisions, but knowing they exist helps people advocate for themselves.
Switching medications. Moving to an antidepressant from a different class (e.g., from an SSRI to an SNRI, bupropion, or mirtazapine) helps some people who didn't respond to the first.
Augmentation. Adding a second agent to boost the antidepressant's effect. Common augmenting agents include certain atypical antipsychotics (at low doses), lithium, or thyroid hormone. These have solid evidence in treatment-resistant cases.
Combining with therapy. If medication alone has been the approach, adding CBT or another evidence-based therapy substantially improves outcomes. The combination consistently outperforms either alone in resistant depression.
TMS (transcranial magnetic stimulation). A non-invasive treatment that uses magnetic pulses to stimulate regions of the brain involved in mood regulation. It's FDA-cleared for treatment-resistant depression, done in a series of outpatient sessions, and doesn't require anesthesia or cause the systemic side effects of medication. Response rates in resistant depression are meaningful.
Ketamine and esketamine. Ketamine works through a completely different mechanism than traditional antidepressants and can produce rapid improvement — sometimes within hours to days — in people who haven't responded to other treatments. Esketamine (a nasal spray) is FDA-approved for treatment-resistant depression and administered under medical supervision. The effects can be dramatic but often require ongoing treatment to maintain.
ECT (electroconvulsive therapy). Despite its frightening reputation (largely a product of outdated portrayals), modern ECT is one of the most effective treatments that exists for severe, treatment-resistant depression, particularly when there's high suicide risk or psychotic features. It's done under anesthesia and is far gentler than its cultural image suggests.
Why the label can be misleading
The word "resistant" can land as a kind of verdict — nothing works for me, I'm a lost cause. That reading is both common and wrong.
What treatment-resistant actually means is that the first standard approaches didn't work — not that nothing will. Many people who didn't respond to two antidepressants respond well to augmentation, TMS, ketamine, or ECT. The treatments above exist precisely because first-line treatment doesn't work for everyone, and they have helped enormous numbers of people who'd concluded they were beyond help.
It also doesn't mean you did anything wrong. Treatment response is largely a matter of biology and circumstance, not effort or willpower. Needing a less common treatment is no different from needing a second-line medication for any other condition.
What to do if you're stuck
If you've tried treatment and feel like you're hitting a wall, a few practical steps:
- Ask for a formal review of what you've tried — doses, durations, adherence. Make sure each trial was actually adequate.
- Ask about reassessing the diagnosis — particularly whether bipolar, anxiety, ADHD, trauma, or a medical cause might be in play.
- Ask for a referral to a psychiatrist if you've been managed in primary care. Resistant depression benefits from specialist input.
- Ask specifically about TMS, ketamine/esketamine, and augmentation — these are often not mentioned unless you raise them.
- Keep treating it as solvable. The data support that stance. Most people who persist through several treatment strategies do find something that helps.
A note on screening
The PHQ-9 is useful not just for initial screening but for tracking — it's designed to be repeated over time to measure whether a treatment is working. If you're in treatment and unsure whether you're improving, periodic PHQ-9 scores give an objective trend line that can inform the conversation about whether to adjust. A score that isn't moving after an adequate trial is exactly the kind of concrete signal that helps a clinician decide what to try next.
If you're in crisis, call or text 988 (US Suicide & Crisis Lifeline), text HOME to 741741, or visit findahelpline.com. This article is for educational purposes and is not a substitute for professional medical advice.